Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma.
Minerva Gastroenterol (Torino)
; 67(1): 4-10, 2021 03.
Article
in En
| MEDLINE
| ID: mdl-33222429
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Antineoplastic Agents, Immunological
/
Immune Checkpoint Inhibitors
/
Liver Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Minerva Gastroenterol (Torino)
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: